HIV and meth prevention study for HIV-negative men
Part of Infections, Mental health clinical trials.
This study tests a smartphone program to help HIV-negative men who have sex with men reduce meth use and improve PrEP adherence. It explores whether combining support for both behaviors is more effective than addressing them separately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are HIV-negative.
- You are a cis-gender man (assigned male at birth and identify as male).
- You are between 18 and 40 years old.
- You have used methamphetamine at a mild to moderate level in the past year.
- You have had anal sex with at least one male partner in the past 6 months.
- You started daily PrEP (HIV prevention pill) more than 30 days ago but have sometimes missed doses in the past month.
- You are willing to use a smartphone app and attend virtual study visits for 6 months.
- You live in San Diego County or San Francisco County.
- You are willing to learn how to collect your own blood spot samples from a finger prick.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help men who use stimulants and are at risk for HIV reduce drug use and prevent HIV infection. Participants may get access to PrEP, a daily pill that prevents HIV, and support to lower their risk.
This study tests two ways to help men who were assigned male at birth and use methamphetamine stay motivated to start PrEP, a medicine that prevents HIV. You may join if you are HIV-negative or don't know your status and haven't taken PrEP recently.
This study looks at how feeling judged or stigmatized for being Latino and for using meth may affect your interest in taking PrEP, a daily pill that prevents HIV. The researchers want to understand these experiences to better help men like you stay healthy.
This study tests a program to help men who have sex with men start and stick with PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to use and reduce HIV risk.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study tests a smartphone program to help young men who have sex with men stay healthy and prevent HIV. It's designed for people already getting care at certain clinics.
Hear when a new PrEP Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.